EXHIBIT 16.1

 

 

Audit • Tax • Consulting • Financial Advisory

Registered with Public Company Accounting Oversight Board (PCAOB)

 

 

August 18, 2025

 

Securities and Exchange Commission

Office of the Chief Accountant

100 F Street, NE

Washington, D.C. 20549

 

Re:

Goldenwell Biotech, Inc.

 

Dear Sir or Madam:

 

We have read the statements under item 4.01 in the Form 8-K dated August 18, 2025, of Goldenwell Biotech, Inc. (the “Company”), and we agree with such statements therein as related to our firm. We have no basis to, and therefore, do not agree or disagree with the other statements made by the Company in the Form 8-K.

 

Very truly yours,

 

 

 

/s/ KCCW Accountancy Corp

 

Diamond Bar, CA